Clinical Trial Update: N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating N-acetylcysteine for smoking cessation in individuals with tobacco and cannabis co-use has completed. The study was sponsored …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Substance Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ellen Herbst | Conditions: Cannabis Use, Tobacco Use Disorder | Phase 4 | Status: COMPLETED